Investigations For Suspected Cardiac Chest Pain - PowerPoint PPT Presentation

1 / 62
About This Presentation
Title:

Investigations For Suspected Cardiac Chest Pain

Description:

Investigations For Suspected Cardiac Chest Pain – PowerPoint PPT presentation

Number of Views:1248
Avg rating:3.0/5.0
Slides: 63
Provided by: RSHA8
Category:

less

Transcript and Presenter's Notes

Title: Investigations For Suspected Cardiac Chest Pain


1
Investigations For Suspected Cardiac Chest Pain
  • Dr Rajan Sharma
  • Consultant Cardiologist
  • Ealing Hospital

2
Diagnostic Tools
  • Functional
  • Exercise ECG
  • Stress Echo
  • Myocardial Perfusion Scanning
  • Stress CMR
  • Anatomy
  • Coronary Angiography
  • Cardiac CT
  • CMR Angiography
  • Carotid Ultrasound

3
General Principles
  • The interpretation of any cardiac investigation
    very heavily dependent on history and clinical
    status
  • All of the available tests are cost effective if
    selected properly
  • In NW London all of these tests are available
  • For all investigations, the operator is as
    important as the test itself

4
Indications For Functional Test
  • Diagnosis of CAD in pts with CP
  • Functional significance of coronary stenosis
    targeted revascularisation
  • Risk stratification
  • before non-cardiac Surgery
  • early after MI
  • in pts with stable angina
  • prior to ICD
  • Detection of viability
  • Valve Disease

5
The Ischaemic Cascade
Chest pain
ECG Changes
Systolic Dysfunction
Regional Wall Motion Abnormality
Temporal sequence of ischaemic events
Diastolic Dysfunction
Metabolic alteration
Perfusion defect
Rest
Stress
6
(No Transcript)
7
Accuracy of Cardiac Imaging Techniques for
Ischaemia Dx
Bax JJ et al. JACC 2002301451-60
8
Exercise Testing
  • Cardiac workload gradually increased by walking
    up an incline
  • ECG, heart rate and blood pressure monitored
  • Development of symptoms, new ECG changes or
    abnormal BP response at a low workload indicates
    coronary disease
  • Cheap and safe and many nurse led RACP clinics
    now set up
  • Limitations if resting ECG abnormal or patient
    has poor exercise tolerance

9
(No Transcript)
10
Interpretation
  • Normal Exercise gt 6 minutes with no symptoms or
    significant ECG changes and good haemodynamic
    response (gt 85 THR)
  • Positive Chest pain, significant ECG changes or
    drop in BP at early change
  • Inconclusive Inability to achieve at least 85
    THR, short exercise time, non specific ECG
    changes at high workload

11
41 year old male with sharp pains in chest at
rest. Father had MI aged 72.
12
12 mins 2 secs of Full Bruce Protocol. 94 THR
achieved.
13
(No Transcript)
14
(No Transcript)
15
46 male with chest tightness on effort. Diabetic
with raised cholesterol.
16
Test stopped at 1 minute 30 secs with chest
tightness.
17
(No Transcript)
18
Stress Echocardiography
  • Safe with few contraindications
  • Procedure takes 40-60 minutes
  • Dobutamine, dipyridamole, exercise, pacing can be
    used as stress agent
  • Deterioration in wall motion signifies ischaemia
  • Accuracy from research studies not always
    reproduced clinically
  • Reproducibility improved with better frame rates,
    digital acquisition and recognised need for
    specialist training

19
(No Transcript)
20
Procedure
21
Semi Quantitative Assessment
  • 1 normal
  • 2 hypokinetic
  • 3 akinetic
  • 4 dyskinetic
  • WMSI total score/
  • total no. segments analysed

The test is considered positive if there is a
deterioration of wall motion in normal or
hypokinetic segments at rest compared with stress.
22
(No Transcript)
23
(No Transcript)
24
Low
Rest
Peak
Recovery
25
(No Transcript)
26
(No Transcript)
27
(No Transcript)
28
LIMITATIONS

Poor endocardial border definition
Complex fibre architecture


Semi quantitative technique
  • Dobutamine non physiological
  • Limited scan planes with echo

Streeter DD 1979
29
Contrast Agents
Improved endocardial border definition improves
accuracy and reproducibility of technique. Should
be used when 2 or more LV segments not visualised
30
(No Transcript)
31
(No Transcript)
32
(No Transcript)
33
Myocardial Viability
34
Motion of scar tissue and TDI
35
Myocardial Contrast Echo
36
(No Transcript)
37
Myocardial Perfusion Imaging
  • Intravenous administration of radioisotope
    followed by imaging of radioactivity with gamma
    camera
  • Thallium 201, technetium-99m-sestamibi,
    technetium-99m-tetrofosmin, commonly used
    isotopes
  • Stress induced by exercise, dipyridamole,
    adenosine or dobutamine
  • Comparison of rest and stress images allows
    detection of ischaemia or infarction

38
Interpretation
  • A normal MPI very good prognostic sign
  • Poor prognostic markers are gt 10 myocardium
    ischaemic, dilatation of LV cavity with stress,
    increased lung uptake of tracer during stress
  • Accuracy maintained in women

39
(No Transcript)
40
(No Transcript)
41
(No Transcript)
42
Cardiac MRI (CMR)
  • Rapidly developing technique with increasing
    availability and indications
  • 1 unable to tolerate scan due to claustrophobia
  • No limitation with imaging planes allowing
    complete anatomical assessment of complex disease

43
Cardiac MRI
44
CMR for CAD
  • Stress CMR
  • Gadolinium enhancement for viability
  • Perfusion CMR
  • CMR Angiography

45
(No Transcript)
46
Contrast Enhancement in Infarction
Ex-vivo comparison of TTC and Gd-enhanced MR
47
Subendocardial MI vs Transmural MI
48
Cardiac CT
  • Coronary calcification usually indicates the
    presence of atherosclerosis
  • A calcium score calculated from total area of
    calcium multiplied by density weighting
  • Agaston Calcium Score gt 300 is significant with
    high sensitivity but moderate specificity
  • Role of CT calcium score in screening
    asymptomatic patients remains controversial
  • Contrast enhanced CT highly effective at
    visualising lumen of proximal two thirds of
    coronary arteries
  • Requires small but significant radiation dose

49
Coronary Calcification
  • Although there is a positive correlation between
    the site and the amount of coronary artery
    calcium and the percent of coronary luminal
    narrowing at the same anatomic site, the relation
    is nonlinear and has large confidence limits
  • The relation of arterial calcification, like that
    of angiographic coronary artery stenosis, to the
    probability of plaque rupture is unknown
  • There is no known relationship between vulnerable
    plaque and coronary artery calcification
  • Although radiographically detected coronary
    artery calcium can provide an estimate of total
    coronary plaque burden, due to arterial
    remodeling, calcium does not concentrate
    exclusively at sites with severe coronary artery
    stenoses

2007 ACCF/AHA Expert Consensus Document
50
The Procedure
  • EBCT and MDCT are fast CT techniques currently
    deployed
  • Thirty to 40 adjacent axial scans usually are
    obtained.
  • A calcium scoring system has been devised based
    on the X-ray attenuation coefficient, or CT
    number measured in Hounsfield units, and the area
    of calcium deposits
  • A fast CT study for coronary artery calcium
    measurement is completed within 10 to 15 min,
    requiring only a few seconds of scanning time
  • Coronary Calcium (Agaston) Score calculated by
    automated tracing of each coronary artery

51
Coronary Artery Calcium Score And Survival
Budoff M et al. JACC 200749(18)1871-73
52
Incremental Benefit of CAC Score vs Framingham
Risk
Budoff M et al. JACC 200749(18)1871-73
53
Annual CVS Event Rate According To Coronary
Artery Calcium Score
Greenland P et al. JACC 200749(3)378-402
54
CAC, Ethnicity and Cardiac Events
Robert D et al. NEJM 20083581336-45
55
2007 ACCF/AHA Expert Consensus Document
  • It may be reasonable to consider use of CAC
    measurement in intermediate risk patients (10
    20 10 yr CVS risk). This conclusion is based on
    the possibility that such patients might be
    reclassified to a higher risk status based on
    high CAC score, and subsequent patient management
    may be modified. Patients with a low CAC score
    should still be considered as intermediate risk.
  • The Committee does not recommend use of CAC
    measurement in low and high CVS risk patients. In
    particular high risk patients should already be
    considered for intensive risk reduction.
  • There is no clear evidence that additional
    non-invasive testing in intermediate risk
    patients with high CAC score (gt 400) will result
    in more appropriate selection of treatments.

56
Coronary Angiography
  • Still gold standard for coronary anatomy
  • Significant side effects rare (1 in 500)
  • Smaller sheaths, closure devices and radial
    access now means this is a day case procedure
  • Not practical or cost effective for routine
    screening of CAD
  • Investigation of choice to plan management in
    patients with high probability of CAD

57
Problems
  • Underestimates plaque burden
  • Gives anatomical information only
  • May lead to unnecessary revascularisation in
    minimally symptomatic patients with stable CAD
  • In low CAD patients has small risk and not always
    cost effective

58
Distribution of CAD According to Angiographic
Severity in Renal Transplant Candidates
29 N 36
36 N 45
14 N 17
21 N 27
R Sharma et al. Nephrol Dial Trans.
200520(10)2207-14
59
Functional Assessment of Angiographic Stenosis
  • IVUS

Pressure Wire
60
Angiography underestimates atherosclerotic burden
Patients (n44) with suspected CAD and normal
angiograms
Atheroma on IVUS
No atheroma on IVUS
52
48
Erbel R et al. Eur Heart J 1996 17 880889
61
CONCLUSIONS What I Do
  • For ETT if good mobility and baseline ECG normal
  • If ETT normal then patient reassured
  • If ETT positive for coronary angiogram
  • If ETT inconclusive for functional test if
    symptoms atypical and few risk factors if
    history good and multiple risk factors for
    coronary angiogram
  • If unable to ETT then for functional test
  • Any positive functional test to be considered for
    coronary angiography
  • Consider CT angiography if very difficult
    vascular access or unable to selectively engage
    artery

62
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com